EdgarLookup

Jasper Therapeutics, Inc. — 8-K Filings

73 8-K filings on record

This page lists all 8-K filings submitted to the SEC by Jasper Therapeutics, Inc. (JSPRW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Jasper Therapeutics, Inc. has filed 73 8-K documents with the SEC since 2019. To view all SEC filings by Jasper Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 25-NSE 3 3/A 4 424B3 424B4 424B5 425 8-A12B 8-K 8-K/A ARS CERT CORRESP DEF 14A DEFA14A DRS EFFECT NT 10-Q POS AM PRE 14A S-1 S-1/A S-3 S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-26-002329 Jan 8, 2026
8-K CURRENT REPORT 0001213900-26-002185 Jan 7, 2026 Jan 2, 2026
8-K CURRENT REPORT 0001213900-25-116943 Dec 2, 2025
8-K CURRENT REPORT 0001213900-25-107874 Nov 10, 2025
8-K CURRENT REPORT 0001213900-25-089584 Sep 19, 2025 Sep 18, 2025
8-K CURRENT REPORT 0001213900-25-075678 Aug 13, 2025
8-K CURRENT REPORT 0001213900-25-062194 Jul 9, 2025 Jul 8, 2025
8-K CURRENT REPORT 0001213900-25-061632 Jul 7, 2025
8-K CURRENT REPORT 0001213900-25-061471 Jul 3, 2025
8-K CURRENT REPORT 0001213900-25-054465 Jun 16, 2025 Jun 14, 2025
8-K CURRENT REPORT 0001213900-25-042017 May 12, 2025
8-K CURRENT REPORT 0001213900-25-025123 Mar 19, 2025 Mar 14, 2025
8-K CURRENT REPORT 0001213900-25-017656 Feb 27, 2025
8-K CURRENT REPORT 0001213900-25-001810 Jan 8, 2025
8-K CURRENT REPORT 0001213900-24-095175 Nov 7, 2024
8-K CURRENT REPORT 0001213900-24-087394 Oct 15, 2024 Oct 14, 2024
8-K CURRENT REPORT 0001213900-24-053982 Jun 20, 2024 Jun 17, 2024
8-K CURRENT REPORT 0001213900-24-051891 Jun 12, 2024 Jun 6, 2024
8-K CURRENT REPORT 0001213900-24-019249 Mar 4, 2024
8-K CURRENT REPORT 0001213900-24-010267 Feb 6, 2024
8-K CURRENT REPORT 0001213900-24-000980 Jan 4, 2024 Jan 3, 2024
8-K CURRENT REPORT 0001213900-24-000056 Jan 2, 2024
8-K CURRENT REPORT 0001213900-23-097100 Dec 20, 2023 Dec 15, 2023
8-K CURRENT REPORT 0001213900-23-084938 Nov 9, 2023
8-K CURRENT REPORT 0001213900-23-081941 Nov 1, 2023 Oct 30, 2023
8-K CURRENT REPORT 0001013762-23-005230 Oct 20, 2023 Oct 18, 2023
8-K CURRENT REPORT 0001213900-23-081286 Oct 10, 2023
8-K CURRENT REPORT 0001213900-23-081265 Oct 10, 2023 Oct 9, 2023
8-K CURRENT REPORT 0001213900-23-078927 Sep 25, 2023 Sep 21, 2023
8-K CURRENT REPORT 0001213900-23-078145 Sep 21, 2023
8-K CURRENT REPORT 0001213900-23-066233 Aug 11, 2023
8-K CURRENT REPORT 0001213900-23-050029 Jun 20, 2023
8-K CURRENT REPORT 0001213900-23-047446 Jun 8, 2023 Jun 2, 2023
8-K CURRENT REPORT 0001213900-23-045834 Jun 2, 2023
8-K CURRENT REPORT 0001213900-23-038997 May 12, 2023
8-K CURRENT REPORT 0001213900-23-029872 Apr 14, 2023 Apr 13, 2023
8-K CURRENT REPORT 0001213900-23-018537 Mar 8, 2023
8-K CURRENT REPORT 0001213900-23-012596 Feb 17, 2023 Feb 16, 2023
8-K CURRENT REPORT 0001213900-23-012446 Feb 16, 2023
8-K CURRENT REPORT 0001213900-23-005582 Jan 27, 2023
8-K CURRENT REPORT 0001213900-23-005155 Jan 25, 2023
8-K CURRENT REPORT 0001213900-23-004843 Jan 24, 2023
8-K CURRENT REPORT 0001213900-23-003597 Jan 19, 2023 Jan 18, 2023
8-K CURRENT REPORT 0001213900-23-002591 Jan 13, 2023
8-K CURRENT REPORT 0001213900-23-001835 Jan 10, 2023
8-K CURRENT REPORT 0001213900-22-071292 Nov 10, 2022
8-K CURRENT REPRT 0001213900-22-071153 Nov 10, 2022
8-K CURRENT REPORT 0001213900-22-069368 Nov 4, 2022 Nov 3, 2022
8-K CURRENT REPORT 0001213900-22-047374 Aug 12, 2022
8-K CURRENT REPORT 0001213900-22-035178 Jun 27, 2022 Jun 23, 2022